Skip to main content
Premium Trial:

Request an Annual Quote

Silence, Dainippon Expand siRNA Delivery Collaboration

Premium

Silence Therapeutics this week announced that its ongoing siRNA-delivery collaboration with Japan's Dainippon Sumitomo Pharma has been expanded to include additional targets.

The companies' collaboration, which was first announced in September (see RNAi News, 9/3/2009), calls for Silence to “demonstrate the functional delivery” of its proprietary siRNA molecules, in combination with its in-house AtuPlex delivery technology, to undisclosed targets provided by Dainippon.

Under the expanded deal, Silence will continue this work against new targets selected by Dainippon. Financial terms of the arrangement were not disclosed.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.